Non-inferiority of ILPS versus glargine was assessed by comparing the upper limit of 95 % confidence intervals ( CIs ) for change in haemoglobin A1c ( HbA1c ) from baseline to week 24 ( adjusted for baseline HbA1c ) with non-inferiority margin 0.4 % .